Guardant Health at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
Guardant Health brings 1 presentation to ISLB 2026 in Madrid, and exhibits at Booth 2. Its work centres on following breast and lung cancer over time with plasma tumour DNA testing. One study checks whether a plasma liquid biopsy assay gives the same HLA and drug-response gene results as sequencing of the white cell layer of blood.
| Organization | ISLB 2026 Attendance |
|---|---|
Guardant Health Palo Alto, CA | ◆Gold Sponsor |
Blood and tissue cancer tests for screening, recurrence monitoring and treatment selection, plus real-world data and analytics for drug developers. | Booth Exhibiting at Booth 2 Sat, Nov 710:00am–4:00pm, 6:00–7:30pmSun, Nov 810:00am–4:00pmMon, Nov 98:30am–10:30am Session Sat Nov 7 1:45pm–3:15pm Industry Mon Nov 9 8:00am–9:00am |
Instantly find 20 buyers from Guardant Health
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction